US Stock MarketDetailed Quotes

ELVN Enliven Therapeutics

Watchlist
  • 21.115
  • +0.225+1.08%
Trading Mar 20 15:33 ET
1.03BMarket Cap-11.17P/E (TTM)

Enliven Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
25.17%104.55M
18.33%26.9M
11.63%27.07M
22.20%24.6M
58.28%25.99M
115.33%83.53M
123.64%22.73M
121.77%24.25M
123.31%20.13M
89.19%16.42M
Selling and administrative expenses
25.43%23.78M
27.94%6.17M
25.16%5.81M
16.68%5.78M
32.59%6.02M
143.98%18.96M
145.37%4.82M
49.50%4.64M
358.85%4.95M
180.30%4.54M
-General and administrative expense
25.43%23.78M
27.94%6.17M
25.16%5.81M
16.68%5.78M
32.59%6.02M
143.98%18.96M
145.37%4.82M
49.50%4.64M
358.85%4.95M
180.30%4.54M
Research and development costs
25.09%80.78M
15.74%20.72M
8.43%21.26M
23.99%18.83M
68.10%19.97M
108.16%64.57M
118.43%17.91M
150.43%19.61M
91.29%15.18M
68.30%11.88M
Operating profit
-25.17%-104.55M
-18.33%-26.9M
-11.63%-27.07M
-22.20%-24.6M
-58.28%-25.99M
-115.33%-83.53M
-123.64%-22.73M
-121.77%-24.25M
-123.31%-20.13M
-89.19%-16.42M
Net non-operating interest income expense
24.43%14.89M
10.33%3.72M
9.94%3.84M
19.72%4.09M
91.85%3.25M
959.96%11.97M
449.43%3.37M
818.95%3.49M
2,587.40%3.41M
18,722.22%1.69M
Non-operating interest income
24.43%14.89M
10.33%3.72M
9.94%3.84M
19.72%4.09M
91.85%3.25M
959.96%11.97M
449.43%3.37M
818.95%3.49M
2,587.40%3.41M
18,722.22%1.69M
Other net income (expense)
4,059.09%871K
0
661.54%73K
799K
-1K
-22K
-9K
-13K
Special income (charges)
--873K
--0
--73K
--800K
----
--0
--0
--0
--0
----
-Less：Restructuring and merger&acquisition
---873K
--0
---73K
---800K
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
90.91%-2K
--0
----
---1K
---1K
---22K
---9K
---13K
----
----
Income before tax
-24.04%-88.79M
-19.67%-23.18M
-11.49%-23.16M
-17.92%-19.72M
-54.43%-22.74M
-90.07%-71.58M
-102.83%-19.37M
-96.79%-20.77M
-88.11%-16.72M
-69.85%-14.72M
Income tax
232K
0
0
232K
0
0
0
0
Net income
-24.36%-89.02M
-19.67%-23.18M
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-90.07%-71.58M
-102.83%-19.37M
-96.79%-20.77M
-88.11%-16.72M
-69.85%-14.72M
Net income continuous Operations
-24.36%-89.02M
-19.67%-23.18M
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-90.07%-71.58M
-102.83%-19.37M
-96.79%-20.77M
-88.11%-16.72M
-69.85%-14.72M
Minority interest income
Net income attributable to the parent company
-24.36%-89.02M
-19.67%-23.18M
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-90.07%-71.58M
-102.83%-19.37M
-96.79%-20.77M
-88.11%-16.72M
-69.85%-14.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-24.36%-89.02M
-19.67%-23.18M
-11.49%-23.16M
-19.31%-19.95M
-54.43%-22.74M
-90.07%-71.58M
-102.83%-19.37M
-96.79%-20.77M
-88.11%-16.72M
-69.85%-14.72M
Basic earnings per share
5.97%-1.89
0.00%-0.46
5.88%-0.48
0.00%-0.41
32.50%-0.54
-119.35%-2.01
-97.97%-0.46
-98.61%-0.51
-89.57%-0.41
-279.28%-0.8
Diluted earnings per share
5.97%-1.89
0.00%-0.46
5.88%-0.48
0.00%-0.41
32.50%-0.54
-119.35%-2.01
-97.97%-0.46
-98.61%-0.51
-89.57%-0.41
-279.28%-0.8
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 25.17%104.55M18.33%26.9M11.63%27.07M22.20%24.6M58.28%25.99M115.33%83.53M123.64%22.73M121.77%24.25M123.31%20.13M89.19%16.42M
Selling and administrative expenses 25.43%23.78M27.94%6.17M25.16%5.81M16.68%5.78M32.59%6.02M143.98%18.96M145.37%4.82M49.50%4.64M358.85%4.95M180.30%4.54M
-General and administrative expense 25.43%23.78M27.94%6.17M25.16%5.81M16.68%5.78M32.59%6.02M143.98%18.96M145.37%4.82M49.50%4.64M358.85%4.95M180.30%4.54M
Research and development costs 25.09%80.78M15.74%20.72M8.43%21.26M23.99%18.83M68.10%19.97M108.16%64.57M118.43%17.91M150.43%19.61M91.29%15.18M68.30%11.88M
Operating profit -25.17%-104.55M-18.33%-26.9M-11.63%-27.07M-22.20%-24.6M-58.28%-25.99M-115.33%-83.53M-123.64%-22.73M-121.77%-24.25M-123.31%-20.13M-89.19%-16.42M
Net non-operating interest income expense 24.43%14.89M10.33%3.72M9.94%3.84M19.72%4.09M91.85%3.25M959.96%11.97M449.43%3.37M818.95%3.49M2,587.40%3.41M18,722.22%1.69M
Non-operating interest income 24.43%14.89M10.33%3.72M9.94%3.84M19.72%4.09M91.85%3.25M959.96%11.97M449.43%3.37M818.95%3.49M2,587.40%3.41M18,722.22%1.69M
Other net income (expense) 4,059.09%871K0661.54%73K799K-1K-22K-9K-13K
Special income (charges) --873K--0--73K--800K------0--0--0--0----
-Less：Restructuring and merger&acquisition ---873K--0---73K---800K------0--0--0--0----
Other non- operating income (expenses) 90.91%-2K--0-------1K---1K---22K---9K---13K--------
Income before tax -24.04%-88.79M-19.67%-23.18M-11.49%-23.16M-17.92%-19.72M-54.43%-22.74M-90.07%-71.58M-102.83%-19.37M-96.79%-20.77M-88.11%-16.72M-69.85%-14.72M
Income tax 232K00232K0000
Net income -24.36%-89.02M-19.67%-23.18M-11.49%-23.16M-19.31%-19.95M-54.43%-22.74M-90.07%-71.58M-102.83%-19.37M-96.79%-20.77M-88.11%-16.72M-69.85%-14.72M
Net income continuous Operations -24.36%-89.02M-19.67%-23.18M-11.49%-23.16M-19.31%-19.95M-54.43%-22.74M-90.07%-71.58M-102.83%-19.37M-96.79%-20.77M-88.11%-16.72M-69.85%-14.72M
Minority interest income
Net income attributable to the parent company -24.36%-89.02M-19.67%-23.18M-11.49%-23.16M-19.31%-19.95M-54.43%-22.74M-90.07%-71.58M-102.83%-19.37M-96.79%-20.77M-88.11%-16.72M-69.85%-14.72M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -24.36%-89.02M-19.67%-23.18M-11.49%-23.16M-19.31%-19.95M-54.43%-22.74M-90.07%-71.58M-102.83%-19.37M-96.79%-20.77M-88.11%-16.72M-69.85%-14.72M
Basic earnings per share 5.97%-1.890.00%-0.465.88%-0.480.00%-0.4132.50%-0.54-119.35%-2.01-97.97%-0.46-98.61%-0.51-89.57%-0.41-279.28%-0.8
Diluted earnings per share 5.97%-1.890.00%-0.465.88%-0.480.00%-0.4132.50%-0.54-119.35%-2.01-97.97%-0.46-98.61%-0.51-89.57%-0.41-279.28%-0.8
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Taylor Morrison Home
TMHC
+1.54%
D.R. Horton
DHI
+0.83%
Meta Platforms
META
+0.81%
Meritage Homes
MTH
+0.72%
Adobe
ADBE
+0.55%

Unlock the Full List